OXBDF closed yesterday lower at $7.92, a decrease of -5.49% from Monday's close, completing a monthly decrease of -1.68% or -$0.14. Over the past 12 months, OXBDF stock lost -10.51%.
OXBDF is not paying dividends to its shareholders.
The last earnings report, released on Apr 09, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Oxford Biomedica plc has completed 1 stock splits, with the recent split occurring on May 30, 2018.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on LSE (GBX).